Entamoeba Medical therapy can successfully cure invasive disease, including amoebic liver abscesses.The protozoan parasite Entamoeba histolytica, possibly other Entamoeba spp. Fecal-oral route, either directly by person-to-person contact (such as by diaper-changing or sexual practices) or indirectly by eating or drinking fecally contaminated food or water. Amoebiasis, a disease caused by the intestinal protozoan parasite Entamoeba histolytica, is the third leading parasitic cause of death in humans after malaria and schistosomiasis.
A sample of returned travelers who sought health care from 2007 through 2011 at any of 53 international GeoSentinel-associated clinics showed that most people diagnosed with E. histolytica had traveled for tourism. Molecular methods using the polymerase chain reaction amplify E. histolytica genes from extracted faecal DNA. Sensitivity and specificity are high (80%–100% and 100%, respectively). The advantage of molecular detection is that it is extremely sensitive.
For symptomatic intestinal infection and extraintestinal disease, treatment with metronidazole or tinidazole should be followed by treatment with iodoquinol or paromomycin. Most patients have a gradual illness onset days or weeks after infection. Symptoms include cramps, watery or bloody diarrhea, and weight loss and may last several weeks.